# Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction

> **NCT00507455** · PHASE2 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 222 (actual)

## Conditions studied

- Lower Urinary Tract Symptoms
- Bladder Outlet Obstruction

## Interventions

- **DRUG:** solifenacin succinate
- **DRUG:** tamsulosin hydrochloride
- **DRUG:** Placebo to solifenacin
- **DRUG:** Placebo to tamsulosin

## Key facts

- **NCT ID:** NCT00507455
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 222 (ACTUAL)
- **Last updated:** 2014-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00507455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00507455, "Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00507455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*